Fundraising Fox

Edwards Lifesciences

NYSE: EW

Irvine, US · Delaware corporation · 3 known investors

Edwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.

BiotechHealthtechMedical Devices

Founders & leadership

DE
Donald E. Bobo, Jr.inCorporate Vice President
SBScott B. Ullem
Scott B. UlleminChief Financial Officer2014–2026
LLLarry L. Wood
Larry L. WoodinCorporate Vice President, Transcatheter Heart Valves2007–2025
HWHuimin Wang
Huimin WanginCorporate Vice President: Irvine, USA2013–2022
CMCatherine M. Szyman
Catherine M. SzymanExecutive
BJBernard J. Zovighian
Bernard J. ZovighianinChief Executive Officer

Board

WJ
William J. LinkBoard director
NJ
Nicholas J. ValerianiBoard director
SR
Steven R. LorangerBoard director
WW
Wesley W. von SchackBoard director
LS
Leslie S. HeiszBoard director
JT
John T. CardisBoard director

Investors · 3

ALIVE Israel HealthTech FundSavyon
Peregrine VenturesOr Yehuda · $500K – $3M
Versant Venture AIV HoldingsreportedSan Francisco

Reported raises · per SEC filings

Form D private placements

$307.2M disclosed across 2 rounds · 2017–2018

▶$34.9MraisedJun 2018 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William J. LinkDirector
  • Kieran T. GallahueDirector
  • Jean-Luc LemercierExecutive Officer
  • Leslie S. HeiszDirector
  • Donald E. Bobo, Jr.Executive Officer
  • Nicholas J. ValerianiDirector
  • Steven R. LorangerDirector
  • Wesley W. von SchackDirector
  • Martha H. MarshDirector
  • Catherine M. SzymanExecutive Officer
  • Larry L. WoodExecutive Officer
  • Michael A. MussallemExecutive Officer, Director
  • Huimin WangExecutive Officer
  • Scott B. UllemExecutive Officer
Offering amount
$34.9M
Amount sold
$34.9M
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$272.4MraisedFeb 2017 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nicholas J. ValerianiDirector
  • William J. LinkDirector
  • Steven R. LorangerDirector
  • Donald E. Bobo, Jr.Executive Officer
  • Wesley W. von SchackDirector
  • Scott B. UllemExecutive Officer
  • Larry L. WoodExecutive Officer
  • Leslie S. HeiszDirector
  • Huimin WangExecutive Officer
  • Catherine M. SzymanExecutive Officer
  • John T. CardisDirector
  • Bernard J. ZovighianExecutive Officer
  • Michael A. MussallemExecutive Officer, Director
  • Patrick VerguetExecutive Officer
  • Kieran GallahueDirector
  • Martha H. MarshDirector
Offering amount
$272.4M
Amount sold
$272.4M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

5 people who came through Edwards Lifesciences went on to found or lead other companies.

Terri BurkeVice President - Global Marketing and Business Development; Surgical Enablers ProgramFounded Protaryx MedicalTodd BrintonChief Scientific Officer & Corporate Vice PresidentFounded Shockwave MedicalTak CheungDirector, Business DevelopmentFounded Lexington Medical, IncDustin ArmerSenior Manager, R&DFounded Renata MedicalEnrico PasquinoSenior Director Clinical Programs EuropeFounded Aorticlab

Competitors · 1

by search overlap
Rf Surgical663 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Companies competing with Edwards Lifesciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Acquisitions · 1

Early investors' stakes continue via these deals
Harpoon Medical, Inc.

University of Maryland spin-out commercializing minimally invasive image-guided surgical tool for beating heart mitral valve repair (acquired by Edwards Lifesciences in December 2017).

In the news

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit 2026 - BioSpacebiospace.com · Sep 2026Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stockbarchart.com · Aug 2026Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boomfinance.yahoo.com · Aug 2026Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event?finance.yahoo.com · Aug 2026Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?barchart.com · Aug 2026Piper Sandler raises Edwards Lifesciences stock price target on earnings beat By Investing.cominvesting.com · Jul 2026

Frequently asked questions

What does Edwards Lifesciences do?
Edwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Who are Edwards Lifesciences's investors?
Edwards Lifesciences's investors include ALIVE Israel HealthTech Fund, Peregrine Ventures, Versant Venture AIV Holdings.
How much funding has Edwards Lifesciences raised?
Edwards Lifesciences has disclosed $307.2M raised across 2 rounds.
Where is Edwards Lifesciences headquartered?
Edwards Lifesciences is headquartered in Irvine, US.